Cipla stock tanks 8% after USFDA warning over issues at MP unit

[ad_1] Shares of pharma giant Cipla Ltd plunged as much as 8% to hit an intraday low of ₹1165.10 apiece on BSE after the United States Food and Drug Administration (USFDA)…

US FDA flags ‘significant violations’ of CGMP norms at Gujarat-based Intas Pharma

[ad_1] The US federal health agency Food and Drug Administration (USFDA) has issued a warning letter to Gujarat-based Intas Pharmaceuticals for “significant violations” in following current good manufacturing practice (CGMP)…